Aidapak Recalls Glucosamine/Chondroitin Capsules Due to Labeling Errors
Aidapak Services, LLC is recalling Glucosamine/Chondroitin DS capsules because they may be mislabeled as other medications. The products were distributed in four western states.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a labeling error (label mixup) without reported injuries or illnesses, fitting the criteria for moderate severity.
Plain-English summary
Aidapak Services, LLC is recalling specific lots of GLUCOSAMINE/CHONDROITIN DS, Capsule, 500 mg/400 mg, Over The Counter. The recall is due to a labeling error where the product may be mislabeled as Glycopyrrolate, Pregabalin, or Multivitamin/Multimineral products.
The affected repacked drugs were distributed in Arizona, California, Oregon, and Washington. The specific lots involved have pedigree codes AD21846_14, W003316, and AD73521_16, with expiration dates ranging from May 1, 2014, to June 18, 2014.
Consumers should check their medication labels and stop using the product if it matches the recalled description. They should contact their pharmacist or the recalling firm for further instructions.
The recalled product
- Product
- GLUCOSAMINE/CHONDROITIN DS, Capsule, 500 mg/400 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904548152
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Over-the-Counter
- Hazard
- Affected units
- 180
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (8)
- GLUCOSAMINE/CHONDROITIN DS
- Capsule
- 500 mg/400 mg has the following codes Pedigree: AD21846_14
- EXP: 5/1/2014
- Pedigree: W003316
- EXP: 6/18/2014
- Pedigree: AD73521_16
- EXP: 5/30/2014.
Distribution
Part of a larger recall action
This product is one of 273 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 273 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- High
- ModerateRecall of MPR Single Use Tourniquet Cuffs Due to Incorrect Expiration Dates
FDA (Devices) · 2026-10-07
- ModeratePercussionaire Recalls Intrapulmonary Percussive Ventilation Devices Due to Labeling Warning
FDA (Devices) · 2026-10-07
- ModerateASP Global Recalls Disposable Tourniquet Cuffs Due to Incorrect Expiration Dates
FDA (Devices) · 2026-10-07
- ModerateASP Global Recalls Disposable Tourniquet Cuffs Due to Incorrect Expiration Dates
FDA (Devices) · 2026-10-07
Similar recalls
- ModerateAidapak Recalls Chlordiazepoxide Capsules Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Glycopyrrolate Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Pyridoxine HCL Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Pregabalin Capsules Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Hydrocortisone Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- SevereAidapak Recalls Cholecalciferol Capsules Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29